Clinical Trial Update: Comparative Study of the Immunogenicity of MMR (Measles, Mumps and Rubella) Single Dose and Multidose Presentations [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing immunogenicity of single-dose versus multidose measles-mumps-rubella vaccine presentations completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Measles
• Mumps
• Rubella

Drugs mentioned

• MMR vaccine (Measles, Mumps, and Rubella vaccine)

Snippet

Sponsor: The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) | Conditions: Measles, Mumps | Phase 4 | Status: COMPLETED